AwardedCzechiaGoodsCZK 65,600,000
Kardiaka 12 - Mavakamten
- Published
- Published 8 May 2026
- Deadline
- Closed 9 June 2026
Overview
The Institut klinické a experimentální medicíny procured regular supplies of pharmaceutical preparations containing mavakamten (ATC C01EB24) for treating patients in approved indications. Bristol-Myers Squibb spol. s r.o. won the contract on 23 June 2026 for 65,564,002 CZK.
Key details
- Country
- Czechia
- Status
- Awarded
- Category
- Goods
- Estimated value
- CZK 65,600,000
- Procedure
- Open
- SME suitable
- Yes
- Published
- 8 May 2026
- Deadline
- Closed
Cardiac therapy medicinal products
Award outcome
- Awarded value
- CZK 65,564,002
- Award date
- 23 June 2026
- Contract period
- 10 July 2026 → 10 August 2030
- Bristol-Myers Squibb spol. s r.o.
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
20 July 2026
Contract Notice
14 May 2026
Contract Notice
8 May 2026
Contracting authority
Institut klinické a experimentální medicíny
Procuring entityPraha, Czechia
Authority website ↗
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.